Sonoscape Medical Corp(300633) : report on changes in shareholding of directors, supervisors and senior managers of the company

Securities code: 300633 securities abbreviation: Sonoscape Medical Corp(300633) Announcement No.: 2021-067 Sonoscape Medical Corp(300633)

Report on changes in shareholding of directors, supervisors and senior managers of the company

The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.

According to the reply on approving Sonoscape Medical Corp(300633) to issue shares to specific objects for registration (zjxk [2021] No. 668) issued by China Securities Regulatory Commission, Sonoscape Medical Corp(300633) (hereinafter referred to as “the company”) issued 27851745 RMB common shares (A shares) to specific objects at an issue price of 27.79 yuan / share, with a total amount of raised funds

773999993.55 yuan and 769055967.35 yuan in net amount. As of December 22, 2021, all the above funds have been in place. Tianjian Certified Public Accountants (special general partnership) has verified the arrival of the raised funds in the company’s special account and issued the Sonoscape Medical Corp(300633) capital verification report (Tianjian Yan [2021] No. 3-78).

All directors, supervisors and senior managers of the company are not the subscription objects of the shares issued to specific objects this time. After the registration of the shares corresponding to the issuance, the total share capital of the company increased accordingly, the number of shares held by the directors, supervisors and senior managers of the company did not change, and the shareholding ratio was diluted due to the increase of the total share capital. The specific changes are as follows:

Before and after the share registration

Name and title

Number of shares (shares) shareholding ratio number of shares (shares) shareholding ratio

Chairman Chen Zhiqiang 9572520023.82% 9572520022.27%

Wu Kunxiang, director and general manager 9572520023.82% 9572520022.27%

Huang Yibo, director and deputy general manager, 200956134.9999% 200956134.68% Manager

Zhou Wenping, director and deputy general manager 155038003.86% 155038003.61% Manager

Sun independent director—-

Bin (Sun Bin)

Hua Xiaoning independent director—-

Xu Shunzhi independent director—-

Chen Xin, chairman of the board of supervisors—-

Supervisor Lin Qihua—-

Zhou Yulu supervisor 112000.00% 112000.00%

JIANREN

Yuan Jian, deputy general manager—-

(person)

Luo Yuezuo, chief financial officer—-

Li Hao, deputy general manager 79632401.98%

Note: the above holdings are the direct holdings of directors, supervisors and senior managers.

It is hereby announced.

Sonoscape Medical Corp(300633) board of directors December 31, 2021

 

- Advertisment -